Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) Meeting Abstract


Authors: Dunn, L.; Ho, A. L.; Haque, S.; Fury, M. G.; Baxi, S. S.; Cullen, G.; Pfister, D. G.; Sherman, E. J.
Abstract Title: Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC)
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036903442
PROVIDER: wos
Notes: Meeting Abstract: e17064 -- Source: Wos
MSK Authors
  1. Eric J Sherman
    149 Sherman
  2. Sofia S Haque
    72 Haque
  3. David G Pfister
    247 Pfister
  4. Shrujal S Baxi
    69 Baxi
  5. Matthew G Fury
    93 Fury
  6. Alan Loh Ho
    79 Ho
  7. Lara   Dunn
    24 Dunn
  8. Grace Dalton Cullen
    5 Cullen